[Epidemiology of age related macular degeneration].

[1]  M. Brantley,et al.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy , 2009, Eye.

[2]  N. Cheung,et al.  Method to increase the sensitivity of perimetric trend progression analysis , 2008, British Journal of Ophthalmology.

[3]  R. Klein,et al.  The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. , 2008, Archives of ophthalmology.

[4]  P. Mitchell,et al.  Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. , 2008, Ophthalmology.

[5]  P. D. de Jong,et al.  Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. , 2008, The American journal of clinical nutrition.

[6]  C. Klinge,et al.  Resveratrol stimulates nitric oxide production by increasing estrogen receptor αa‐Src‐caveolin‐1 interaction and phosphorylation in human umbilical vein endothelial cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  T. Wong,et al.  Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. , 2008, Archives of ophthalmology.

[8]  A. Fletcher,et al.  Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. , 2008, Ophthalmology.

[9]  A. Luff,et al.  An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment , 2008, Eye.

[10]  J. Ott,et al.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.

[11]  Julie A Simpson,et al.  Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. , 2008, American journal of ophthalmology.

[12]  T. Peto,et al.  Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland. The Greenland Inuit Eye Study. , 2008, Ophthalmology.

[13]  R. Klein,et al.  Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. , 2008, American journal of ophthalmology.

[14]  P. Mitchell,et al.  Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2008, Ophthalmology.

[15]  M. Brantley,et al.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. , 2007, Ophthalmology.

[16]  T. Ianchulev,et al.  Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients. , 2007, Ophthalmology.

[17]  R. Lamuela-Raventós,et al.  Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. , 2007, The American journal of clinical nutrition.

[18]  F. Ferris,et al.  The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. , 2007, Archives of ophthalmology.

[19]  P. Mitchell,et al.  Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2007, Ophthalmology.

[20]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[21]  J. Ott,et al.  The LOC387715 Gene, Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration , 2007, Human Heredity.

[22]  G. Murthy,et al.  Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. , 2007, Investigative ophthalmology & visual science.

[23]  R. Klein,et al.  Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. , 2007, American journal of ophthalmology.

[24]  P. Bernstein,et al.  Evaluation of 4-Methylpyrazole as a Potential Therapeutic Dark Adaptation Inhibitor , 2007, Current eye research.

[25]  K. Gawrisch,et al.  Evidence for Specificity in Lipid-Rhodopsin Interactions* , 2006, Journal of Biological Chemistry.

[26]  R. Klein,et al.  Age-Related Macular Degeneration and Risk for Stroke , 2006, Annals of Internal Medicine.

[27]  B. Rosner,et al.  Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. , 2006, Archives of ophthalmology.

[28]  P. Barberger‐Gateau,et al.  Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. , 2006, Investigative ophthalmology & visual science.

[29]  Usha Chakravarthy,et al.  Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). , 2006, Archives of ophthalmology.

[30]  Alan Grossfield,et al.  A role for direct interactions in the modulation of rhodopsin by ω-3 polyunsaturated lipids , 2006 .

[31]  A. Hofman,et al.  Dietary intake of antioxidants and risk of age-related macular degeneration. , 2005, JAMA.

[32]  D. Clayton,et al.  Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation , 2005, British Journal of Ophthalmology.

[33]  T. Das,et al.  Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. , 2005, Investigative ophthalmology & visual science.

[34]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[35]  C. Delcourt,et al.  The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study. , 2005, American journal of ophthalmology.

[36]  Y. Nose,et al.  The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. , 2005, Investigative ophthalmology & visual science.

[37]  T. Clemons,et al.  Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. , 2004, Archives of ophthalmology.

[38]  Frank A Sloan,et al.  Longitudinal prevalence of major eye diseases. , 2003, Archives of ophthalmology.

[39]  R. Willke,et al.  Incidence of exudative age-related macular degeneration among elderly Americans. , 2003, Ophthalmology.

[40]  David I W Phillips,et al.  Lutein and zeaxanthin status and risk of age-related macular degeneration. , 2003, Investigative ophthalmology & visual science.

[41]  B. Rosner,et al.  Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. , 2003, Archives of ophthalmology.

[42]  A. Bird,et al.  The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study. , 2003, Acta ophthalmologica Scandinavica.

[43]  T. Peto,et al.  5-year incidence of age-related maculopathy in the Reykjavik Eye Study. , 2003, Ophthalmology.

[44]  Johanna M Seddon,et al.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.

[45]  Paul Mitchell,et al.  Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. , 2003, Archives of ophthalmology.

[46]  Ronald Klein,et al.  The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2003, Ophthalmology.

[47]  Y. Nose,et al.  Risk factors for age related maculopathy in a Japanese population: the Hisayama study , 2003, The British journal of ophthalmology.

[48]  D. C. Mitchell,et al.  Enhancement of G protein-coupled signaling by DHA phospholipids , 2003, Lipids.

[49]  P. Mitchell,et al.  Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. , 2002, Ophthalmology.

[50]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[51]  P. Mitchell,et al.  Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. , 2002, Archives of ophthalmology.

[52]  S. Resnikoff,et al.  Visual impairment and blindness in Europe and their prevention , 2002, The British journal of ophthalmology.

[53]  B. Sumpio,et al.  Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. , 2002, Journal of vascular surgery.

[54]  Paul Mitchell,et al.  Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.

[55]  R. Klein,et al.  Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. , 2001, Archives of ophthalmology.

[56]  C. Delcourt,et al.  Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. , 2001, Archives of ophthalmology.

[57]  Y. Kiyohara,et al.  Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study , 2001, The British journal of ophthalmology.

[58]  R. Glynn,et al.  Body mass index and the incidence of visually significant age-related maculopathy in men. , 2001, Archives of ophthalmology.

[59]  W. Willett,et al.  Dietary fat and risk for advanced age-related macular degeneration. , 2001, Archives of ophthalmology.

[60]  E. Rimm,et al.  Prospective study of zinc intake and the risk of age-related macular degeneration. , 2001, Annals of epidemiology.

[61]  A Hofman,et al.  Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.

[62]  R. Klein,et al.  Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. , 2001, American journal of epidemiology.

[63]  C. Delcourt,et al.  Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study , 2001, Ophthalmic epidemiology.

[64]  A. Simopoulos.  Human requirement for N-3 polyunsaturated fatty acids. , 2000, Poultry science.

[65]  C. Delcourt,et al.  Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age. , 1999, Archives of ophthalmology.

[66]  R. Klein,et al.  Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. , 1999, Archives of ophthalmology.

[67]  S C Jensen,et al.  Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. , 1999, Ophthalmology.

[68]  Annette Ostenfeld‐Åkerblom.  Age-related macular degeneration in Inuit. , 1999, Acta ophthalmologica Scandinavica.

[69]  C. Delcourt,et al.  Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age. , 1998, Archives of ophthalmology.

[70]  S. Nigdikar,et al.  Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. , 1998, The American journal of clinical nutrition.

[71]  R. Klein,et al.  Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. , 1998, American journal of epidemiology.

[72]  C. Duijn,et al.  Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.

[73]  A. Munnich,et al.  The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration , 1998 .

[74]  J. C. Smith,et al.  Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. , 1997, Analytical chemistry.

[75]  W. Willett,et al.  A prospective study of cigarette smoking and age-related macular degeneration in women. , 1996, JAMA.

[76]  R. Klein,et al.  Smoke gets in your eyes too. , 1996, JAMA.

[77]  R J Glynn,et al.  A prospective study of cigarette smoking and risk of age-related macular degeneration in men. , 1996, JAMA.

[78]  M. C. Leske,et al.  Features of Age-Related Macular Degeneration in a Black Population , 1995 .

[79]  E. Diamandis,et al.  The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[80]  Lawrence A. Yannuzzi,et al.  Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .

[81]  R Hiller,et al.  Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. , 1994, JAMA.

[82]  B Rosner,et al.  Vitamin A supplementation for retinitis pigmentosa. , 1993, Archives of ophthalmology.

[83]  F. Khachik,et al.  Separation, identification, and quantification of carotenoids in fruits, vegetables and human plasma by high performance liquid chromatography , 1991 .

[84]  T. Rosenberg.  Prevalence of blindness caused by senile macular degeneration in Greenland. , 1987, Arctic medical research.

[85]  D M Snodderly,et al.  The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. , 1984, Investigative ophthalmology & visual science.

[86]  F. Delori,et al.  The macular pigment. II. Spatial distribution in primate retinas. , 1984, Investigative ophthalmology & visual science.

[87]  R. Klein,et al.  Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. , 2007, Ophthalmology.

[88]  Paul Mitchell,et al.  Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.

[89]  P. D. de Jong,et al.  Cigarette smoking and age-related macular degeneration in the EUREYE Study. , 2007, Ophthalmology.

[90]  A Hofman,et al.  Incidence and progression rates of age-related maculopathy: the Rotterdam Study. , 2001, Investigative ophthalmology & visual science.

[91]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[92]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.

[93]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[94]  T. Rosenberg.  Prevalence and causes of blindness in Greenland. , 1987, Arctic medical research.

[95]  S. Fliesler,et al.  Chemistry and metabolism of lipids in the vertebrate retina. , 1983, Progress in lipid research.

[96]  M. Brown,et al.  Modulation of Rhodopsin Function by Properties of the Membrane Bilayer , 2022 .